Paliperidone
INVEGA, INVEGA HAFYERA, INVEGA SUSTENNA, INVEGA TRINZA
Atypical Antipsychotic
NADAC/unit
$0.9776
No Shortage
Tier 1: 310.0%
PA Req: 198.5%
11 Manufacturers
39 ANDAs
Paliperidone treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.
vs. brand INVEGA: Generic saves up to 90% per unit
Generic Manufacturers
AJANTA PHARMA LTDALEMBIC PHARMACEUTICALS LTDAMNEAL PHARMACEUTICALS OF NEW YORK LLCAPOTEX INCASCENT PHARMACEUTICALS INCCSPC OUYI PHARMACEUTICAL CO LTDDR REDDYS LABORATORIES LTDESKAYEF PHARMACEUTICALS LTDINVENTIA HEALTHCARE LTDJANSSEN PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.